3Lindholm A, Kahan BD. Influence of cyclosporine pharmacokinetics, trough concentrations, and AUC monitoring on outcome after kidney transplantation[J]. Clin pharmacol Ther, 1993,55;205.
4Mahalati K, Belitsky P, Sketris I, et al. Neoral monitoring by simplified sparse sampling area under the concentration - time curve[J]. Translantation, 1999,68; 55.
5Johnston A, David OJ, Cooney GF. Pharmacokinetic validation of Neoral absorption profiling[J]. Transplant Proc, 2000, 32(3): 53.
6Bjom N, Edward C, Gary L, et al. Clinical validation studies of Neoral C2 monitoring: a review[J]. Transplantation, 2002,73(9): 3.
7Halloran PF, Helms LM, Kung L, et al. The temporal profile of calcineurin inhibition by cyclosporine in vivo [J ]. Transplantation, 1999, 68:1356.
8Hesselink DA,Smak PJ ,Weimar W. The use of cyclos-porine in renal transplantation[J]. Transplatation Proc, 2004,36(1) : 328.
9Shishido S,Asanuma H, Nakai H, et al .The impact of repeated subclinical acute rejection on the progression of chronic allograft nephropathy[J] .J- Am -Soc- Nephrol, 2003,14(4) : 1 046.
10Woo YC, Jong AH, Young KW, et al . Reconstruction for renal artery aneurysm: Operative techniques and long- term results[J] .Journal of Vascular Surgery,2003,37(2): 293.
